Technical Analysis
HCLTECH’s current share price is around ₹1,460-1,533, trading below all key moving averages (MA5: ₹1,472, MA20: ₹1,495, MA50: ₹1,518, MA200: ₹1,603), signaling strong selling pressure. RSI(14) at 19.27 is oversold, STOCHRSI at 12.82 oversold, MACD at -14.28 shows selling momentum, while ADX above 69 confirms a strong downtrend. Support levels at ₹1,457-1,461 (pivot-based), resistance at ₹1,470-1,475; potential upside breakout, but short-term bearish.
Fundamental Analysis
Q3 FY26 revenue grew 4.2% QoQ CC, crossing $15B annualized, with bookings at record $3B. EBIT margin recovered to 18.6%, ROIC at 38.1% (LTM), FCF strong at 121% of net income. FY26 guidance: revenue 4-4.5% YoY CC, services 4.75-5.25%; market cap ₹3.96L Cr, PE 34.6, ROCE 30.84%. Revenue mix: Americas 56.5%, financial services 21%, life sciences 15.9%.
Reasons for Continuous Decline
18% drop in the past year mainly due to Q1FY26 profit down 3% YoY, EBIT margin contraction to 16.3% (utilization drop, AI training investments, client bankruptcy). Recent 4-day losing streak: 11.76% down amid sector pressure and margin headwinds.
AI Impact
AI investments (OpenAI partnership, Agentic AI Force 2.0) caused short-term margin pressure (training costs), but long-term positive—$100M AI revenue, AI-led deal growth (e.g., $473M retailer deal). Brokerages bullish: Nomura Buy TP ₹1,660, Jefferies Buy TP ₹1,730, citing AI services focus. Further downside risk low if AI adoption accelerates; position building viable at current oversold levels (₹1,460 support).
Recent News Events
February 2026 investor meets: Nuvama India Conference (9-11 Feb), Kotak Chasing Growth (23-26 Feb), IIFL Enterprising India (24-26 Feb)—no price-sensitive info. Q3FY26 strong bookings and AI partnerships (Zscaler, GSMA, DIB) positive impact.
Positive News
Q3FY26 revenue crosses $15B, bookings $3B.
AI revenue $100M, bullish brokerage calls (Motilal Oswal Buy TP ₹1,800).
Strong FCF, dividend yield 3.52%.
Negative News
Continued downtrend, 11.76% recent drop.
Margin pressure, subdued life sciences vertical.
Shares fell despite FY26 guidance revision.
Macro View
IT sector pressure from US trade deal hopes and AI deflation (8-10% over 2-3 years), but HCLTECH’s AI services focus and $15B revenue provide strength. Global tech spending rise positive.
Micro View
Services growth 4.75-5.25%, AI-led deals ($473M TCV), but short-term challenges from utilization and acquisition integration.
Disclaimer and Disclosure
This analysis is for informational purposes only, not investment advice. Markets involve risk; consult independent advisors before investing. We/our affiliates hold no position in HCLTECH. As SEBI-registered research analysts, we comply with all regulations.